Scope Forward, published by Becker's GI & Endoscopy, reaches gastroenterologists and endoscopists who are frontline decision-makers for ordering liver cancer screening in clinical practice.
Scope Forward reports that starting April 2026, providers with a Quest account can order HelioLiver — a test designed for early detection of hepatocellular carcinoma — through Quest's network of approximately 7,700 patient service centers. The article notes the test will integrate into existing provider workflows and electronic health records systems.